why choose us

Clinical Trials Search

Showing 11,110 of 132,963 result(s)
RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease

Status: NOT_YET_RECRUITING

Condition: Crohn Disease

Interventions: Induction and maintenance treatment

Date: 2023-06-09

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer

Status: NOT_YET_RECRUITING

Condition: Breast Cancer Invasive

Interventions: an irreversible anti-HER2 tyrosine kinase inhibitor

Date: 2023-06-09

Rebound Pain and Related Factors in Postoperative Patients With Total Knee Arthroplasty

Status: NOT_YET_RECRUITING

Condition: Postoperative Pain

Interventions:

Date: 2023-06-09

A Detailed Look At What Patients Experience When They Take Part In Hypertension Clinical Trials

Status: NOT_YET_RECRUITING

Condition: Hypertension

Interventions:

Date: 2023-06-09

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Karelizumab Combined With Etoposide and Cisplatin

Status: NOT_YET_RECRUITING

Condition: Carcinoma

Interventions: Karelizumab?200 mg?ivgtt?D1?q3w? Cisplatin?75 mg;m2?ivgtt?D1?q3w? Etoposide?100 mg;m2?ivgtt?D1~3?q3w

Date: 2023-06-09

Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

Status: NOT_YET_RECRUITING

Condition: Rectal Cancer

Interventions:

Date: 2023-06-09

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Status: NOT_YET_RECRUITING

Condition: Melanoma

Interventions: Dose Escalation and expansion of INCB 99280 with Ipilimumab

Date: 2023-06-09

Effectiveness of TheRApeutic ExercIse aNd EDucation on Patients With Massive Rotator Cuff Tears

Status: NOT_YET_RECRUITING

Condition: Rotator Cuff Injuries

Interventions: Therapeutic exercise program based on individualized progressive resistance exercises performed during 6 months at home, with a frequency of 1-3 sessi

Date: 2023-06-09

Deploying Emergency Bystander Internet Training

Status: NOT_YET_RECRUITING

Condition: Trauma

Interventions: Participants in both study arms will undergo a half-day first responder training course designed for laypeople.
The course will consist of five c

Date: 2023-06-09

Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

Status: NOT_YET_RECRUITING

Condition: Head and Neck Squamous Cell Carcinoma

Interventions: Administered intravenously

Date: 2023-06-09